A. Stern

发表

Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation.

W. Fibbe, E. Gluckman, A. Bacigalupo, 1992, Blood.

GM-CSF Combined with Low-Dose Cytosine Arabinoside: A Trial Proposed for High-Risk Myelodysplastic Syndromes and Results of a Dose-Finding Study

H. Gerhartz, H. Schmetzer, B. Wolf-Hornung, 1992 .

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF)

H. Gerhartz, P. Sonneveld, R. Marcus, 1992, Infection.

Recombinant Hum an Granulocyte -Ma crop hage Colony- Stimulating Fact or Accelerates Neutrophil and Monocyte Recovery After Allogeneic T-Cell-Depleted Bone Marrow Transplantation

É., A. Gratwohl, T. Witte, 2003 .

Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factor

R. Willemze, W. Fibbe, H. Haak, 1991, Annals of Hematology.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.

W. Fleischhacker, M. Hummer, H. Zwierzina, 1992, The Journal of clinical psychiatry.

Accidental Overdose of Multiple Chemotherapeutic Agents

A. Gratwohl, A. Tichelli, M. Hausmann, 1989, The Korean journal of internal medicine.

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

H. Gerhartz, M. Baccarani, F. Mandelli, 1992, Annals of Hematology.

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

H. Gerhartz, M. Baccarani, F. Mandelli, 1992, Annals of Hematology.